200 million euros for Ortivity

Pan-European private equity investor Apheon has found a new partner for its portfolio company Ortivity. The investment by Unigestion, an international private equity firm with a focus on mid-market investments, is intended to provide targeted support for the company's expansion.

Capital inflow of around 200 million euros

As part of the transaction, Unigestion is investing around 200 million euros and acquiring a minority stake in Ortivity. At the same time, existing shareholders will have the option of a partial exit. Apheon remains the main investor and is expanding its commitment.

We want to set new standards in patient-centered care and consistently expand our network.

Dr. med. Michael Thorwarth, Co-CEO

The fresh funds will primarily be used to implement Ortivity's growth plans and to further professionalize the company's structures.

Ortivity as a platform for outpatient orthopaedics

Ortivity was founded in 2022 by a group of leading doctors together with Apheon. The company has quickly developed into one of the largest platforms for outpatient orthopaedic care in Germany.

Today, Ortivity operates more than 100 locations, which are divided into three regional clusters. A wide range of services is offered: from diagnostics and surgery to anesthesia, prevention and aftercare.

A special feature of the business model is the close cooperation with doctors. Ortivity is owned in equal parts by doctors and investors.

Expansion of regional clusters

With the support of Unigestion, Apheon and Ortivity intend to continue their expansion in Germany. The plan is to strengthen existing clusters as well as develop new regions. The physician-led model is to be consistently developed further in order to offer patients an integrated range of care.

Ortivity's rapid growth shows the potential of outpatient care models. We look forward to helping shape the next chapter of this success story.

Philipp Scheier, Unigestion

Representatives of Apheon emphasize that Unigestion impressed them during the partner search as a cooperative and growth-oriented partner. Unigestion emphasizes that Ortivity's development since its foundation demonstrates the potential of outpatient care models. The company sees the investment as an important milestone in strengthening its capital base and further expanding its care network.

Next steps

The transaction is still subject to regulatory approvals. Once this has been completed, Ortivity will consolidate its role as a leading provider in the field of outpatient orthopaedic care and initiate the next phase of growth.